Survival after liver transplantation from hepatitis B-core positive donors at a quaternary care hospital in Brazil

Braz J Infect Dis. 2024 Nov-Dec;28(6):104384. doi: 10.1016/j.bjid.2024.104384. Epub 2024 Oct 11.

Abstract

Background: Liver transplantation is the treatment for many end-stage liver diseases and hepatocellular carcinoma but shortage of available organs poses significant challenge. Many centers have used grafts from donors with positive anti-HBc serology but concerns about potential hepatitis B virus reactivation and de novo hepatitis B infection have raised questions about the safety of this approach. This study aimed to evaluate the survival of liver transplant recipients from anti-HBc-positive-donors and assess the risk of hepatitis B reactivation and de novo hepatitis B.

Patients and methods: A retrospective single-center cohort study was conducted from 2002 to 2018, comparing who received grafts from anti-HBc-positive-donors to those from anti-HBc-negative-donors. The primary outcome was survival and description cases of hepatitis B reactivation/de novo hepatitis B.

Results: We analyzed 1,111 liver transplants, in which 993 (89 %) received grafts from anti-HBc-negative-donors and 118 (11 %) from anti-HBc-positive-donors. Median age of recipients from anti-HBc-positive donors was 56 years and from anti-HBc-negative donors was of 53 years (p = 0.001). Male sex was predominant in both groups. Factors associated with death in multivariate analysis were retransplantation, early allograft dysfunction, high MELD, recipient over 60 years and female donor. The utilization of grafts from anti-HBc-positive-donors did not increase mortality. The majority of HBV reactivation and de novo hepatitis B occurred in anti-HBc positive recipients. The risk of hepatitis B reactivation/de novo hepatitis B was low and manageable.

Conclusion: The study supports safety of liver grafts from anti-HBc-positive donors when employing antiviral prophylaxis. These findings contribute to expand donor options and improve patient outcomes.

Keywords: Anti-HBc-positive donor; Hepatitis B; Liver transplant; Prophylaxis; Survival.

MeSH terms

  • Adult
  • Aged
  • Brazil / epidemiology
  • Female
  • Graft Survival
  • Hepatitis B Antibodies / blood
  • Hepatitis B Core Antigens / immunology
  • Hepatitis B virus / immunology
  • Hepatitis B* / mortality
  • Humans
  • Liver Transplantation* / adverse effects
  • Male
  • Middle Aged
  • Retrospective Studies
  • Risk Factors
  • Tissue Donors*
  • Virus Activation / immunology

Substances

  • Hepatitis B Core Antigens
  • Hepatitis B Antibodies